Literature DB >> 16125709

SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.

William T Wright1, Ian S Young, D Paul Nicholls, Chris Patterson, Kelly Lyttle, Colin A Graham.   

Abstract

Serum triglyceride levels (TG) are important independent risk factors for coronary heart disease. The apolipoproteins C-III (apoCIII) and A-V (apoAV) are central to normal TG metabolism and the complete sequence analysis of these genes was carried out in severe cases (TG > 9 mmol/l) and controls (TG < 2 mmol/l). A total of 53 SNPs were identified in these genes with 17 being novel to this study. Further analysis defined four APOC3 SNPs and three APOA5 SNPs showing strong association with TG levels. Analysis of the two major SNPs from APOA5 [c.56C > G, c.-3A > G] and from APOC3 [c.102C > T, c.340C > G] using THESIAS has identified two major haplotypes relative to the most common CACC haplotype showing very strong association with hypertriglyceridaemia, CGTG and GATC (odds ratio 7.45 and 5.26). Logistic regression analysis of these four SNPs revealed that, carriage of the APOA5 c.56 G allele (odd ratios 4.49) and the APOA5 c.-3 G allele (odds ratio 3.23) were strong independent predictors of hypertriglyceridaemia (P < 0.001), whereas in contrast, carriage of the APOC3 c102 T allele (odds ratio 1.35) and the APOC3 c.340 G allele (odds ratio 1.37), did not show any significant effects that were independent of APOA5.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125709     DOI: 10.1016/j.atherosclerosis.2005.06.043

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  16 in total

1.  Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.

Authors:  G M Dallinga-Thie; A van Tol; H Hattori; L C van Vark-van der Zee; H Jansen; E J G Sijbrands
Journal:  Diabetologia       Date:  2006-04-28       Impact factor: 10.122

2.  Genetic polymorphisms of T-1131C APOA5 and ALOX5AP SG13S114 with the susceptibility of ischaemic stroke in Morocco.

Authors:  Brehima Diakite; Khalil Hamzi; Wiam Hmimech; Sellama Nadifi
Journal:  J Genet       Date:  2016-06       Impact factor: 1.166

3.  Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice.

Authors:  Shen Qu; German Perdomo; Dongming Su; Fiona M D'Souza; Neil S Shachter; H Henry Dong
Journal:  J Lipid Res       Date:  2007-04-16       Impact factor: 5.922

4.  Apolipoprotein A5 gene C56G variant confers risk for the development of large-vessel associated ischemic stroke.

Authors:  Anita Maász; Péter Kisfali; Zoltán Szolnoki; Ferenc Hadarits; Béla Melegh
Journal:  J Neurol       Date:  2008-02-18       Impact factor: 4.849

5.  Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome.

Authors:  Anita Maász; Péter Kisfali; Katalin Horvatovich; Márton Mohás; Lajos Markó; Veronika Csöngei; Bernadett Faragó; Luca Járomi; Lili Magyari; Enikô Sáfrány; Csilla Sipeky; István Wittmann; Béla Melegh
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 3.201

6.  An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients.

Authors:  Clive R Pullinger; Bradley E Aouizerat; Irina Movsesyan; Vincent Durlach; Eric J Sijbrands; Katsuyuki Nakajima; Annie Poon; Geesje M Dallinga-Thie; Hiroaki Hattori; Lauri L Green; Pui-Yan Kwok; Richard J Havel; Philip H Frost; Mary J Malloy; John P Kane
Journal:  J Lipid Res       Date:  2008-04-25       Impact factor: 5.922

Review 7.  Apoprotein A-V: an important regulator of triglyceride metabolism.

Authors:  M Kluger; J Heeren; M Merkel
Journal:  J Inherit Metab Dis       Date:  2008-04-14       Impact factor: 4.982

8.  Linkage disequilibrium decay and haplotype block structure in the pig.

Authors:  Andreia J Amaral; Hendrik-Jan Megens; Richard P M A Crooijmans; Henri C M Heuven; Martien A M Groenen
Journal:  Genetics       Date:  2008-05       Impact factor: 4.562

9.  Modifications to the Patient Rule-Induction Method that utilize non-additive combinations of genetic and environmental effects to define partitions that predict ischemic heart disease.

Authors:  Greg Dyson; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Charles F Sing
Journal:  Genet Epidemiol       Date:  2009-05       Impact factor: 2.135

10.  ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency.

Authors:  Gery Gerritsen; Caroline C van der Hoogt; Frank G Schaap; Peter J Voshol; Kyriakos E Kypreos; Nobuyo Maeda; Albert K Groen; Louis M Havekes; Patrick C N Rensen; Ko Willems van Dijk
Journal:  J Lipid Res       Date:  2008-02-10       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.